Inventor · Balsham, GB

Steven Moss

29Patents
3h-index
28Co-inventors
63Inventor score

Filing activity: Jul 16, 2003 → Sep 14, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US9119853B2 Sanglifehrin based compounds Chemistry; Metallurgy 7 Active
US7648996B2 39-desmethoxy derivatives of rapamycin Human Necessities 7 Active
US8008318B2 39-desmethoxy derivatives of rapamycin Human Necessities 6 Active
US7390895B2 Production of polyketides and other natural products Chemistry; Metallurgy 3 Active
US7300942B2 Production of polyketides and other natural products Chemistry; Metallurgy 3 Expired
US7645768B2 Production of polyketides and other natural products Chemistry; Metallurgy 2 Active
US7560252B2 Borrelidin-producing polyketide synthase and its use Emerging Cross-Sectional Technologies 2 Expired
US10307389B2 Succinate prodrugs for use in the treatment of lactic acidosis or drug-induced side-effects due to Complex I-related impairment of mitochondrial oxidative phosphorylation Human Necessities 2 Active
US11565998B2 Succinate prodrug, compositions containing the succinate prodrug and uses thereof Chemistry; Metallurgy 1 Active
US9040259B2 Production of polyketides and other natural products Chemistry; Metallurgy 1 Active
US9505773B2 Rapamycin analogues and their pharmaceutical use Emerging Cross-Sectional Technologies 0 Active
US9382266B2 Rapamycin analogue Chemistry; Metallurgy 0 Active
US9090657B2 Compound and methods for its production Chemistry; Metallurgy 0 Active
US10919927B2 Immune stimulating macrolide Emerging Cross-Sectional Technologies 0 Active
US12310940B2 Cell-permeable succinate compounds Emerging Cross-Sectional Technologies 0 Active
US11434258B2 Compounds (immunorhelins) Human Necessities 0 Active
US11059845B2 Immune stimulating macrolides Human Necessities 0 Active
US9976165B2 Methods for increasing molecular diversity of polyketides and non-ribosomal proteins Emerging Cross-Sectional Technologies 0 Active
US11147789B2 Cell-permeable succinate compounds Emerging Cross-Sectional Technologies 0 Active
US9504728B2 Dosage form Human Necessities 0 Active
US9605001B2 Production of polyketides and other natural products Chemistry; Metallurgy 0 Active
US9271977B2 Sanglifehrin derivatives and methods for their production Emerging Cross-Sectional Technologies 0 Active
US9139613B2 Macrocyclic compounds and methods for their production Chemistry; Metallurgy 0 Active
US11304990B2 Use of known compounds—intracellular infections Emerging Cross-Sectional Technologies 0 Active
US10857150B2 Use of sanglifehrin macrocyclic analogues as anticancer compounds Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.